Heart failure & cardiomyopathies

Cardiomyopathy-Associated Pathogenic Variants in Pediatric Myocarditis: A Study From the Pediatric Cardiomyopathy Registry

Circ Heart FailPublished Cross-sectional study

Authors' conclusion

Children with DCM secondary to myocarditis had a higher burden of variants in cardiomyopathy-associated genes than that of heart-healthy controls.

Study context

Population
Children with dilated cardiomyopathy (DCM) in the Pediatric Cardiomyopathy Registry who underwent exome sequencing
Exposure
DCM secondary to myocarditis vs heart-healthy controls
  • Myocarditis DCMn = 32
  • Controlsn = 128reference
Outcome
Prevalence of rare predicted-damaging variants in cardiomyopathy-associated genes
Methodological detailsmulticentre registry, matched controls (4:1 on genomic similarity)
  • Multicentre registry
  • Matched controls (4:1 on genomic similarity)

Main finding

As reported in the abstract

Rare predicted-damaging variants

P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeMyocarditis DCMControlsP value
Clinical classification of rare predicted-damaging variants
Pathogenic1/12— not stated in the abstract
Likely pathogenic3/12— not stated in the abstract
Uncertain significance8/12— not stated in the abstract
Benign— not stated in the abstract2/8
Likely benign— not stated in the abstract4/8
Pathogenic/likely pathogenic variantsMyocarditis DCM vs Controls12.5% (95% CI 3.5%–29.0%)0% (95% CI 0%–2.3%)P < 0.01

— not stated in the abstract

Myocarditis DCM vs DCM alone · rare predicted-damaging variants
P = 0.17
Myocarditis DCM vs DCM alone · pathogenic/likely pathogenic variants
P = 1.00

Myocarditis DCM vs DCM alone

Not significantly different

Original publication

Cardiomyopathy-Associated Pathogenic Variants in Pediatric Myocarditis: A Study From the Pediatric Cardiomyopathy Registry. Circ Heart Fail. Published 5 December 2025. doi:10.1161/circheartfailure.125.013104

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.